NEJM 22 Aug 2013 Vol 369 699 Vedolizumab. What a name for an important new drug. Just remember the vedo bit and the fact that it’s a monoclonal antibody, and […]
Richard Lehman’s weekly review of medical journals
Richard Lehman’s journal review—19 August 2013
NEJM 15 Aug 2013 Vol 369 603 A publicly funded trial in the USA, simply called the Prostate Cancer Prevention Trial, examined the effect of finasteride on prostate cancer incidence […]
Richard Lehman’s journal review—12 August 2013
NEJM 8 Aug 2013 Vol 369 507 A phase 1 study of a drug for an arcane cancer gets first place in the NEJM this week, and I think it […]
Richard Lehman’s journal review—5 August 2013
NEJM 1 Aug 2013 Vol 369 397 Shared decision making at the end of life is probably the toughest challenge in medicine. It requires good evidence about a wide range […]
Richard Lehman’s journal review—29 July 2013
JAMA 24-31 July 2013 Vol 310 It’s possible that you want to read about US physicians’ views on their role in cost containment, and about rates of breast cancer survival […]
Richard Lehman’s journal review—22 July 2013
JAMA 17 July 2013 Vol 310 270 There are three papers in this week’s JAMA which would make good teaching material for a course on critical reading. The first is […]
Richard Lehman’s journal review—15 July 2013
JAMA 10 July 2013 Vol 310 149 Fifteen years ago, JAMA was my favourite journal. Its covers were always beautiful, thanks to M Therese Southgate’s choice of paintings and works […]
Richard Lehman’s journal review—8 July 2013
JAMA 3 July 2013 Vol 310 46 If you identify people with poorly controlled blood pressure in primary care and introduce a system of intensive telemonitoring run by pharmacists according […]
Richard Lehman’s journal review—1 July 2013
JAMA 26 June 2013 Vol 309 2557 Now that I’ve conceded column space to killer flu H7N9, let me put your minds at rest. Lots of people are working hard […]
Richard Lehman’s journal blog—24 June 2013
JAMA 19 June 2013 Vol 309 2449 If you give live attenuated measles, mumps and rubella vaccine to children with juvenile rheumatoid arthritis who are on immune suppressing treatment, are […]